NIH faces marching orders on orphan drug shortage.
作者信息
Dolgin Elie
出版信息
Nat Med. 2011 May;17(5):522. doi: 10.1038/nm0511-522b.
PMID:21546953
Abstract
摘要
相似文献
1
NIH faces marching orders on orphan drug shortage.
Nat Med. 2011 May;17(5):522. doi: 10.1038/nm0511-522b.
2
March on, not in.
Nat Med. 2011 May;17(5):515. doi: 10.1038/nm0511-515.
3
New products highlight ambiguity of orphan drug law.
Nat Biotechnol. 2003 Jan;21(1):6-7. doi: 10.1038/nbt0103-6b.
4
[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech].
Presse Med. 2010 May;39(5):527-9. doi: 10.1016/j.lpm.2010.01.002. Epub 2010 Mar 2.
5
Clinical trial for Fabry disease faces continuing hurdles.
CMAJ. 2009 Nov 24;181(11):E251-2. doi: 10.1503/cmaj.109-3071. Epub 2009 Oct 13.
6
March-in rights under the Bayh-Dole Act: the NIH's paper tiger?
Seton Hall Law Rev. 2013 Nov 1;43(4):1403-32.
7
To march in or not to march in.
Nat Med. 2011 Aug 4;17(8):921; author reply 921-2. doi: 10.1038/nm.2440.
8
A united front.
Nature. 2011 Apr 28;472(7344):389-90. doi: 10.1038/472389b.
9
Shire drops 'emergency' Fabry's disease drug.
Nat Biotechnol. 2012 Jun 7;30(6):478. doi: 10.1038/nbt0612-478c.
10
Experimental use and the Orphan Drug Act: a biotechnology conundrum.
Nat Biotechnol. 1996 Apr;14(4):511-2. doi: 10.1038/nbt0496-511.
引用本文的文献
1
Real-time concentration monitoring using a compact composite sensor array for in situ quality control of aqueous formulations.
J Pharm Biomed Anal. 2021 Nov 30;206:114386. doi: 10.1016/j.jpba.2021.114386. Epub 2021 Sep 20.
2
Online availability and safety of drugs in shortage: a descriptive study of internet vendor characteristics.
J Med Internet Res. 2012 Feb 9;14(1):e27. doi: 10.2196/jmir.1999.
Zotero 插件